New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
07:33 EDTVIVOMeridian Bioscience reports Q1 adjusted EPS 20c, consensus 19c
Reports Q1 revenue $45.4M consensus $44.34M.
News For VIVO From The Last 14 Days
Check below for free stories on VIVO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 28, 2014
07:26 EDTVIVOAmerican Association for Clinical Chemistry to hold annual meeting
Subscribe for More Information
July 24, 2014
08:17 EDTVIVOMeridian Bioscience reaffirms FY14 EPS view 85c-90c, consensus 88c
Reaffirms FY14 revenue view $190M-$195M, consensus $192.97M. Says financial condition is "sound."
08:16 EDTVIVOMeridian Bioscience reports Q3 EPS 21c, consensus 23c
Subscribe for More Information
July 22, 2014
07:08 EDTVIVOLife Sciences highlights this week at Canaccord
Canaccord highlighted six diagnostic names that report this week and recommends buying Top Pick IDEXX (IDXX) into the print given strong recurring razor/razorblade sales and consistent organic growth. The analyst expects Hold rated Quest Diagnostics (DGX) to report upside to Street estimates of $1.06/$1.882B, Quidel (QDEL) to have an uneventful report, Exact Sciences (EXAS) to provide an update on numerous catalysts near-term and Abaxis (ABAX) to report earnings below consensus. Lastly, the firm is cautious on Meridian Bioscience (VIVO) following a competitor report last week.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use